CSI Market
Sign In | Register

Ocular Therapeutix Inc (OCUL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access OCUL quarterly Cash Flow →
The table below presents a historical view of Ocular Therapeutix Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-265.94
Depreciation & amortization4.32
Amortization of Other Assets3.40
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.52
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.03
Share-based Compensation43.18
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Debt Instrument Unamortized Premium-
Discount On Marketable Securities-
Discount Premium On Marketable Securities-
Premium On Marketable Securities-
Operating Lease Right Of Use Asset Amortization-
Derivative Gain Loss On Derivative Net-
Increase Decrease In Contract With Customer Liability-0.13
Derivative Gain Loss On Derivative And Other Net2.47
Increase Decrease In Operating Lease Assets1.31
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.74
Increase (Decrease) in Accounts Payable-0.89
Increase (Decrease) in Accrued Liabilities5.25
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.60
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.65
Discontinued operations0.00
Net Cash flow from Operating Activities-204.88
Investing Activities
Capital Expenditures-12.01
Sale of Capital Items0.13
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-11.88
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock22.14
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Repayments Of Insurance Costs Financed By Third Party-
Proceeds From Paycheck Protection Program Loan-
Repayment Of Paycheck Protection Program Loan-
Proceeds From Issuance Of Protective Advance-
Repayment Of Protective Advance-
Sale Of Stock Consideration Received On Transaction539.59
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities561.72
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-216.76
Total Cash Flow344.96
4 historic quarters locked

Sign in to unlock the full Ocular Therapeutix Inc cash flow history.

Sign In Create Free Account

About Ocular Therapeutix Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-010664

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License